The ‘At Risk’ Patient

November 17, 2017

As part two of an online series, infectious disease experts at Hackensack Meridian Health are on the alert for C. auris. They discuss the implications of the emerging threat of multidrug-resistant fungus and the need for increased surveillance as well as strategies for isolation, especially among those at highest risk, including intensive care and immunocompromised patients. This episode features Jersey Shore University Medical Center infectious disease experts Elliot Frank, M.D. and Susan Hanrahan, R.N., the UV technology being used for disinfection at Jersey Shore, and John Theruer Cancer Center expert Scott Rowley, M.D.

Read full article on medscape.com.